MassBio Feedback Survey: FDA PreCheck Program

MassBio is gathering input on the FDA’s new PreCheck Program, launched in August 2025 to cut red tape for U.S. biomanufacturers and accelerate U.S. pharmaceutical manufacturing by offering earlier engagement on facility design and CMC readiness. The goal: speed approvals, boost supply chain resilience, and make it easier to build and expand domestic capacity.

Your feedback will directly inform MassBio’s public comments to FDA, ensuring the perspective of Massachusetts’ ecosystem is represented. This survey should take about 10 minutes to complete.

Thank you for sharing your expertise.

Section 1: Background

Question Title

* 1. Company Size: How many employees does your company have globally?

1-50

51-200

201-500

501-1,000

1,001-5,000

5,001+

Question Title

* 2. Years in Business: How long has your company been in operation?

Less than 5 years

5-10 years

11-20 years

More than 20 years

Question Title

* 3. Domestic Manufacturing Facilities: Does your company currently operate any U.S.-based manufacturing facilities?

Yes, currently operational

No, but in planning / construction stage

No, and no current plans

14% of survey complete.